QuiVad
My list

Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on September 22, 2026.

Follow

Evolution of the disclosed total

0%0.5%1%1.5%2%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 8.43% on August 19, 2021. The shaded band matches the twelve months of the first chart.

July 23, 2018 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
GSA Capital Partners LLP1.19%newSeptember 22, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

Follow by RSS

Get the moves on Oncopeptides AB by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

439 disclosures on record for this share.
DateFund% of capitalEnd of publication
March 28, 2022GSA Capital Partners LLP1.40%
March 25, 2022Voleon Capital Management LP1.39%
March 22, 2022Arrowstreet Capital Limited Partnership0.00%
March 18, 2022Millennium International Management LP0.00%
March 16, 2022Millennium International Management LP0.70%
March 15, 2022Voleon Capital Management LP1.41%
March 10, 2022Millennium International Management LP0.60%
March 8, 2022PDT Partners LLC0.00%
March 7, 2022PDT Partners LLC0.58%
March 7, 2022Millennium International Management LP0.50%
March 4, 2022PDT Partners LLC0.66%
March 4, 2022Millennium International Management LP0.00%
March 3, 2022Millennium International Management LP0.52%
March 1, 2022Millennium International Management LP0.67%
February 25, 2022Millennium International Management LP0.77%
February 23, 2022Millennium International Management LP0.81%
February 21, 2022GSA Capital Partners LLP1.60%
February 21, 2022Millennium International Management LP0.75%
February 8, 2022GSA Capital Partners LLP1.56%
February 1, 2022GSA Capital Partners LLP1.40%
January 28, 2022GSA Capital Partners LLP1.30%
January 25, 2022GSA Capital Partners LLP1.27%
January 25, 2022Arrowstreet Capital Limited Partnership0.59%
January 20, 2022GSA Capital Partners LLP1.15%
January 19, 2022Voleon Capital Management LP1.07%
January 19, 2022GSA Capital Partners LLP1.00%
January 18, 2022Voleon Capital Management LP0.97%
January 17, 2022GSA Capital Partners LLP0.82%
January 17, 2022PDT Partners LLC0.75%
January 14, 2022Voleon Capital Management LP0.89%
January 11, 2022Voleon Capital Management LP0.99%
January 11, 2022PDT Partners LLC0.82%
December 21, 2021Arrowstreet Capital Limited Partnership0.88%
December 16, 2021Worldquant LLC0.00%
December 10, 2021GSA Capital Partners LLP0.71%
December 8, 2021Worldquant LLC0.50%
December 7, 2021Worldquant LLC0.00%
December 3, 2021GSA Capital Partners LLP0.63%
December 2, 2021Worldquant LLC0.53%
November 30, 2021Millennium International Management LP0.55%
November 29, 2021Millennium International Management LP1.65%
November 29, 2021GSA Capital Partners LLP0.58%
November 26, 2021Millennium International Management LP1.52%
November 25, 2021Millennium International Management LP1.38%
November 25, 2021Worldquant LLC0.00%
November 24, 2021Voleon Capital Management LP1.04%
November 24, 2021Worldquant LLC0.57%
November 23, 2021Millennium International Management LP1.24%
November 23, 2021Voleon Capital Management LP0.63%
November 22, 2021Worldquant LLC0.82%

Download 439 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at September 22, 2026, https://www.quivad.com/action/oncopeptides-ab?page=4